Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratoire de Génétique Moléculaire, |
RCV001027539 | SCV001162834 | likely pathogenic | Hermansky-Pudlak syndrome 9 | 2020-02-20 | criteria provided, single submitter | clinical testing | Patient is having oculocutaneous albinism and severe defect of platelets dense bodies highly suggesting of Hermansky-Pudlak Syndrome. Variant in trans of another variant classified Likely Pathogenic upon ACMG classification. Each parent has one variant. |
Invitae | RCV001027539 | SCV002965327 | pathogenic | Hermansky-Pudlak syndrome 9 | 2023-10-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser67*) in the BLOC1S6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BLOC1S6 are known to be pathogenic (PMID: 10610180, 21665000, 22461475). This variant is present in population databases (rs772475341, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Hermansky-Pudlak syndrome (PMID: 32245340). ClinVar contains an entry for this variant (Variation ID: 827680). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV001027539 | SCV005184310 | pathogenic | Hermansky-Pudlak syndrome 9 | 2024-08-06 | no assertion criteria provided | literature only |